FZAOX
Price
$43.58
Change
+$0.19 (+0.44%)
Updated
Jul 31 closing price
Net Assets
2.4B
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

FZAOX vs VSCIX

FZAOX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
FZAOX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FZAOX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. FZAOX (2.4B). VSCIX pays higher dividends than FZAOX: VSCIX (1.23) vs FZAOX (0.03). FZAOX was incepted earlier than VSCIX: FZAOX (13 years) vs VSCIX (29 years). FZAOX (0.83) is less costly to investors than VSCIX (0.03). FZAOX is a more actively managed with annual turnover of: 34.00 vs. VSCIX (17.00). FZAOX has a lower initial minimum investment than VSCIX: FZAOX (0) vs VSCIX (5000000). FZAOX annual gain was more profitable for investors over the last year : 30.18 vs. VSCIX (22.58). VSCIX return over 5 years is better than : 35.13 vs. FZAOX (18.79).
FZAOXVSCIXFZAOX / VSCIX
Total Expense Ratio0.830.032,767%
Annual Report Gross Expense Ratio0.830.032,767%
Fund Existence13 years29 years-
Gain YTD20.48714.591140%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.4B189B1%
Annual Yield % from dividends0.031.233%
Returns for 1 year30.1822.58134%
Returns for 3 years38.8243.4489%
Returns for 5 years18.7935.1354%
Returns for 10 years67.84156.0743%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C